D‐index as a marker of bloodstream infections in patients with allogeneic hematopoietic stem cell transplantation
- 1 March 2021
- journal article
- research article
- Published by Wiley in Transplant Infectious Disease
- Vol. 23 (4), e13588
- https://doi.org/10.1111/tid.13588
Abstract
Neutropenia is a risk factor for development of infections, however, the direct effect of neutropenia on development of bloodstream infection (BSI) is not known. D‐index, which is area between the neutrophil time curve and a neutrophil count of 0.5 x 109/L, incorporates the combined effect of severity and duration of neutropenia. We aimed to evaluate whether D‐index can be used as a marker for BSI in patients with allogeneic stem cell transplantation. We conducted a retrospective cohort study of patients undergoing allogeneic stem cell transplantation between January 1, 2005, and September 30, 2015. The primary outcome measure was the development of BSI within 30 days of transplantation. A total of 714 patients were included in the study of whom 101 developed BSI. Patients with BSI had a significantly higher median D‐index value compared with patients who did not have BSI (4,990 versus 3,570, P<.001). As a marker, the performance of the D‐index was similar to that of the duration of profound neutropenia (P=0.18) and significantly better than the total duration of neutropenia (P=0.001). The D‐index performed better than the total duration of neutropenia as a marker for BSI in patients with allogeneic stem cell transplantation. There was no difference between D‐index and, a more easily calculable indicator, duration of profound neutropenia.Keywords
Funding Information
- National Center for Advancing Translational Sciences (UL1 TR002377)
This publication has 26 references indexed in Scilit:
- Epidemiology and Outcomes of Clostridium difficile Infections in Hematopoietic Stem Cell Transplant RecipientsClinical Infectious Diseases, 2012
- Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2011
- Intestinal Damage Determines the Inflammatory Response and Early Complications in Patients Receiving Conditioning for a Stem Cell TransplantationPLOS ONE, 2010
- Retrospective Evaluation of the Area Over the Neutrophil Curve Index to Predict Early Infection in Hematopoietic Stem Cell Transplantation RecipientsTransplantation and Cellular Therapy, 2010
- Index to Predict Invasive Mold Infection in High-Risk Neutropenic Patients Based on the Area Over the Neutrophil CurveJournal of Clinical Oncology, 2009
- Factors associated with mortality in bacteremic patients with hematologic malignanciesDiagnostic Microbiology and Infectious Disease, 2009
- Comparison of Real-Time PCR for Detection of the tcdC Gene with Four Toxin Immunoassays and Culture in Diagnosis of Clostridium difficile InfectionJournal of Clinical Microbiology, 2008
- Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patientsCancer, 2006
- Piperacillin–tazobactam monotherapy in high-risk febrile and neutropenic cancer patientsClinical Microbiology & Infection, 2006
- Changes in the Etiology of Bacteremia in Febrile Neutropenic Patients and the Susceptibilities of the Currently Isolated PathogensClinical Infectious Diseases, 2004